At visit 3, the clinician will determine "optimal" stimulant dose based on review of parent and teacher-completed Conners Global Index scales and all available adverse event and side effects data, using procedures similar to those used in other studies. Participants will remain on this optimal stimulant dose for the remainder of the study, unless side effects necessitate some downward dose adjustment.